Ben-Am Monique 4
4 · BIOCANCELL THERAPEUTICS INC. · Filed Mar 28, 2012
Insider Transaction Report
Form 4
BIOCANCELL THERAPEUTICS INC.BICL.TA
Ben-Am Monique
VP Clinical Trials
Transactions
- Award
Employee Options
2011-09-27+200,000→ 200,000 totalExp: 2022-09-27→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The exercise price is 1.86 NIS per share.
- [F2]37,500 options shall vest and be exercisable one year after the grant, and an additional 9,375 options shall vest and be exercisable at the end of each calendar quarter, from June 30, 2012 until 150,000 options are vested or until vesting is terminated in accordance with the terms of the options. An additional 50,000 options shall vest and be exercisable upon achievement of a pre-determined milestone.